Overcoming obstacles to AI-ready healthcare data
If artificial intelligence (AI) is going to remain the top news story for 2023, it has to continue...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
The Token Is Broken: Rethinking Patient Tokenization
Patient tokenization replaces personal identifiers with encrypted tokens to link healthcare records...
Aiding the advancement of Alzheimer’s treatment
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Maternal mental health matters
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Using real-world data to justify coverage for digital health solutions
Today’s most innovative companies are leveraging digital health data solutions to deliver...
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...